位置:首页 > 蛋白库 > SUCP_BIFAA
SUCP_BIFAA
ID   SUCP_BIFAA              Reviewed;         504 AA.
AC   A0ZZH6; Q84HQ2;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 1.
DT   03-AUG-2022, entry version 97.
DE   RecName: Full=Sucrose phosphorylase {ECO:0000303|PubMed:14740189, ECO:0000303|PubMed:14756551, ECO:0000303|PubMed:20691225};
DE            Short=SP {ECO:0000303|PubMed:14756551};
DE            Short=SPase {ECO:0000303|PubMed:20691225};
DE            EC=2.4.1.7 {ECO:0000269|PubMed:14740189, ECO:0000269|PubMed:20691225};
GN   Name=sucP {ECO:0000303|PubMed:14740189};
GN   Synonyms=spl {ECO:0000312|EMBL:BAF38859.1};
GN   OrderedLocusNames=BAD_0078 {ECO:0000312|EMBL:BAF38859.1};
OS   Bifidobacterium adolescentis (strain ATCC 15703 / DSM 20083 / NCTC 11814 /
OS   E194a).
OC   Bacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae;
OC   Bifidobacterium.
OX   NCBI_TaxID=367928;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-15, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY,
RP   AND SUBUNIT.
RC   STRAIN=ATCC 15703 / DSM 20083 / NCTC 11814 / E194a;
RX   PubMed=14740189; DOI=10.1007/s00253-003-1534-x;
RA   van den Broek L.A., van Boxtel E.L., Kievit R.P., Verhoef R., Beldman G.,
RA   Voragen A.G.;
RT   "Physico-chemical and transglucosylation properties of recombinant sucrose
RT   phosphorylase from Bifidobacterium adolescentis DSM20083.";
RL   Appl. Microbiol. Biotechnol. 65:219-227(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15703 / DSM 20083 / NCTC 11814 / E194a;
RA   Suzuki T., Tsuda Y., Kanou N., Inoue T., Kumazaki K., Nagano S., Hirai S.,
RA   Tanaka K., Watanabe K.;
RT   "Bifidobacterium adolescentis complete genome sequence.";
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20691225; DOI=10.1016/j.jbiotec.2010.07.029;
RA   Cerdobbel A., Desmet T., De Winter K., Maertens J., Soetaert W.;
RT   "Increasing the thermostability of sucrose phosphorylase by multipoint
RT   covalent immobilization.";
RL   J. Biotechnol. 150:125-130(2010).
RN   [4] {ECO:0007744|PDB:1R7A}
RP   X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS), SUBUNIT, REACTION MECHANISM, AND
RP   ACTIVE SITE.
RC   STRAIN=ATCC 15703 / DSM 20083 / NCTC 11814 / E194a;
RX   PubMed=14756551; DOI=10.1021/bi0356395;
RA   Sprogoe D., van den Broek L.A., Mirza O., Kastrup J.S., Voragen A.G.,
RA   Gajhede M., Skov L.K.;
RT   "Crystal structure of sucrose phosphorylase from Bifidobacterium
RT   adolescentis.";
RL   Biochemistry 43:1156-1162(2004).
RN   [5] {ECO:0007744|PDB:2GDU, ECO:0007744|PDB:2GDV}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF WILD-TYPE IN COVALENT COMPLEX
RP   WITH BETA-D-GLUCOSE AND MUTANT GLN-232 IN COMPLEX WITH SUCROSE, MUTAGENESIS
RP   OF GLU-232, REACTION MECHANISM, AND ACTIVE SITE.
RX   PubMed=16990265; DOI=10.1074/jbc.m605611200;
RA   Mirza O., Skov L.K., Sprogoe D., van den Broek L.A., Beldman G.,
RA   Kastrup J.S., Gajhede M.;
RT   "Structural rearrangements of sucrose phosphorylase from Bifidobacterium
RT   adolescentis during sucrose conversion.";
RL   J. Biol. Chem. 281:35576-35584(2006).
RN   [6] {ECO:0007744|PDB:5C8B}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF MUTANT PHE-345 IN COMPLEX WITH
RP   BETA-D-GLUCOSE, AND MUTAGENESIS OF GLN-345.
RX   PubMed=26527586; DOI=10.1002/cbic.201500514;
RA   Kraus M., Grimm C., Seibel J.;
RT   "Redesign of the active site of sucrose phosphorylase through a clash-
RT   induced cascade of loop shifts.";
RL   ChemBioChem 17:33-36(2016).
CC   -!- FUNCTION: Catalyzes the reversible phosphorolysis of sucrose into
CC       alpha-D-glucose 1-phosphate (Glc1P) and D-fructose (PubMed:14740189,
CC       PubMed:20691225). Is involved in sucrose degradation. Also displays
CC       transglucosylation activity in vitro, by transferring the glucosyl
CC       moiety of Glc1P to a broad range of monomeric sugars, such as D- and L-
CC       arabinose, D- and L-arabitol, and xylitol (PubMed:14740189).
CC       {ECO:0000269|PubMed:14740189, ECO:0000269|PubMed:20691225}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=phosphate + sucrose = alpha-D-glucose 1-phosphate + D-
CC         fructose; Xref=Rhea:RHEA:24048, ChEBI:CHEBI:17992, ChEBI:CHEBI:37721,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58601; EC=2.4.1.7;
CC         Evidence={ECO:0000269|PubMed:14740189, ECO:0000269|PubMed:20691225};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=6.8 mM for sucrose (at 58 degrees Celsius and pH 6.5)
CC         {ECO:0000269|PubMed:20691225};
CC         Note=kcat is 207 sec(-1) for the phosphorolysis of sucrose (at 58
CC         degrees Celsius and pH 6.5). {ECO:0000269|PubMed:20691225};
CC       pH dependence:
CC         Optimum pH is 6.0-6.5 for the phosphorolysis of sucrose.
CC         {ECO:0000269|PubMed:14740189, ECO:0000269|PubMed:20691225};
CC       Temperature dependence:
CC         Optimum temperature is 48 degrees Celsius for the phosphorolysis of
CC         sucrose (PubMed:14740189). The His-tagged enzyme shows an optimum
CC         temperature of 58 degrees Celsius (PubMed:20691225). The
CC         immobilization of the enzyme on Sepabeads EC-HFA increases
CC         thermostability, and optimum temperature is shifted to 65 degrees
CC         Celsius (PubMed:20691225). {ECO:0000269|PubMed:14740189,
CC         ECO:0000269|PubMed:20691225};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:14740189,
CC       ECO:0000269|PubMed:14756551}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 13 family. Sucrose
CC       phosphorylase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF543301; AAO33821.1; -; Genomic_DNA.
DR   EMBL; AP009256; BAF38859.1; -; Genomic_DNA.
DR   RefSeq; WP_011742626.1; NC_008618.1.
DR   PDB; 1R7A; X-ray; 1.77 A; A/B=1-504.
DR   PDB; 2GDU; X-ray; 2.10 A; A/B=1-504.
DR   PDB; 2GDV; X-ray; 2.00 A; A/B=1-504.
DR   PDB; 5C8B; X-ray; 2.70 A; B=1-504.
DR   PDB; 5M9X; X-ray; 2.35 A; B=1-504.
DR   PDB; 5MAN; X-ray; 2.04 A; B=1-504.
DR   PDB; 5MB2; X-ray; 1.75 A; B=1-504.
DR   PDB; 6FME; X-ray; 1.51 A; A/B=1-504.
DR   PDBsum; 1R7A; -.
DR   PDBsum; 2GDU; -.
DR   PDBsum; 2GDV; -.
DR   PDBsum; 5C8B; -.
DR   PDBsum; 5M9X; -.
DR   PDBsum; 5MAN; -.
DR   PDBsum; 5MB2; -.
DR   PDBsum; 6FME; -.
DR   AlphaFoldDB; A0ZZH6; -.
DR   SMR; A0ZZH6; -.
DR   STRING; 1680.BADO_0067; -.
DR   CAZy; GH13; Glycoside Hydrolase Family 13.
DR   EnsemblBacteria; BAF38859; BAF38859; BAD_0078.
DR   KEGG; bad:BAD_0078; -.
DR   HOGENOM; CLU_021358_1_0_11; -.
DR   OMA; PNATQFT; -.
DR   BRENDA; 2.4.1.7; 842.
DR   Proteomes; UP000008702; Chromosome.
DR   GO; GO:0009018; F:sucrose phosphorylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044262; P:cellular carbohydrate metabolic process; IEA:InterPro.
DR   CDD; cd11355; AmyAc_Sucrose_phosphorylase; 1.
DR   Gene3D; 3.90.400.10; -; 1.
DR   InterPro; IPR006047; Glyco_hydro_13_cat_dom.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR045857; O16G_dom_2.
DR   InterPro; IPR015325; Suc_Porlyase_C.
DR   InterPro; IPR016377; Sucrose_GGa_phosphorylase-rel.
DR   InterPro; IPR022527; Sucrose_phospho.
DR   Pfam; PF00128; Alpha-amylase; 1.
DR   Pfam; PF09244; DUF1964; 1.
DR   PIRSF; PIRSF003059; Sucrose_phosphorylase; 1.
DR   SMART; SM00642; Aamy; 1.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   TIGRFAMs; TIGR03852; sucrose_gtfA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carbohydrate metabolism; Direct protein sequencing;
KW   Glycosyltransferase; Reference proteome; Transferase.
FT   CHAIN           1..504
FT                   /note="Sucrose phosphorylase"
FT                   /id="PRO_0000442435"
FT   ACT_SITE        192
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000269|PubMed:16990265,
FT                   ECO:0000305|PubMed:14756551"
FT   ACT_SITE        232
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:14756551,
FT                   ECO:0000305|PubMed:16990265"
FT   BINDING         50
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:16990265,
FT                   ECO:0007744|PDB:2GDU"
FT   BINDING         88
FT                   /ligand="sucrose"
FT                   /ligand_id="ChEBI:CHEBI:17992"
FT                   /evidence="ECO:0000269|PubMed:16990265,
FT                   ECO:0007744|PDB:2GDU"
FT   BINDING         190..192
FT                   /ligand="sucrose"
FT                   /ligand_id="ChEBI:CHEBI:17992"
FT                   /evidence="ECO:0000269|PubMed:16990265,
FT                   ECO:0007744|PDB:2GDU"
FT   BINDING         232
FT                   /ligand="sucrose"
FT                   /ligand_id="ChEBI:CHEBI:17992"
FT                   /evidence="ECO:0000269|PubMed:16990265,
FT                   ECO:0007744|PDB:2GDU"
FT   BINDING         289..290
FT                   /ligand="sucrose"
FT                   /ligand_id="ChEBI:CHEBI:17992"
FT                   /evidence="ECO:0000269|PubMed:16990265,
FT                   ECO:0007744|PDB:2GDU"
FT   BINDING         342..345
FT                   /ligand="sucrose"
FT                   /ligand_id="ChEBI:CHEBI:17992"
FT                   /evidence="ECO:0000269|PubMed:16990265,
FT                   ECO:0007744|PDB:2GDU"
FT   BINDING         399
FT                   /ligand="sucrose"
FT                   /ligand_id="ChEBI:CHEBI:17992"
FT                   /evidence="ECO:0000269|PubMed:16990265,
FT                   ECO:0007744|PDB:2GDU"
FT   MUTAGEN         232
FT                   /note="E->Q: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16990265"
FT   MUTAGEN         345
FT                   /note="Q->F: Decreases affinity for sucrose. Highly
FT                   improves in vitro activity towards aromatic acceptors,
FT                   allowing efficient glucosylation of resveratrol, (+)-
FT                   catechin and (-)-epicatechin."
FT                   /evidence="ECO:0000269|PubMed:16990265"
FT   STRAND          6..9
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          13..18
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           19..29
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   TURN            31..33
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          35..39
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          46..50
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          56..61
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   TURN            63..65
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           68..74
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   TURN            75..77
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          78..84
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           94..102
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           103..105
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           109..111
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           115..118
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           125..129
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          134..137
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          139..145
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          148..153
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          155..157
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          160..163
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           168..183
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          188..191
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           194..196
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          205..207
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           209..224
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          228..231
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           237..244
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          247..252
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           255..265
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           269..277
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          280..284
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           294..297
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           312..325
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   TURN            326..328
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           329..333
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           335..337
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          338..340
FT                   /evidence="ECO:0007829|PDB:5MAN"
FT   STRAND          343..346
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           350..353
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   TURN            354..356
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           358..370
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          371..378
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           379..382
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           389..395
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           398..402
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           408..414
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           418..432
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           434..437
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          438..445
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   TURN            446..448
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          449..455
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          460..465
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   HELIX           467..470
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          480..486
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   STRAND          489..494
FT                   /evidence="ECO:0007829|PDB:6FME"
FT   TURN            496..498
FT                   /evidence="ECO:0007829|PDB:6FME"
SQ   SEQUENCE   504 AA;  56190 MW;  10705FE3182E5754 CRC64;
     MKNKVQLITY ADRLGDGTIK SMTDILRTRF DGVYDGVHIL PFFTPFDGAD AGFDPIDHTK
     VDERLGSWDD VAELSKTHNI MVDAIVNHMS WESKQFQDVL AKGEESEYYP MFLTMSSVFP
     NGATEEDLAG IYRPRPGLPF THYKFAGKTR LVWVSFTPQQ VDIDTDSDKG WEYLMSIFDQ
     MAASHVSYIR LDAVGYGAKE AGTSCFMTPK TFKLISRLRE EGVKRGLEIL IEVHSYYKKQ
     VEIASKVDRV YDFALPPLLL HALSTGHVEP VAHWTDIRPN NAVTVLDTHD GIGVIDIGSD
     QLDRSLKGLV PDEDVDNLVN TIHANTHGES QAATGAAASN LDLYQVNSTY YSALGCNDQH
     YIAARAVQFF LPGVPQVYYV GALAGKNDME LLRKTNNGRD INRHYYSTAE IDENLKRPVV
     KALNALAKFR NELDAFDGTF SYTTDDDTSI SFTWRGETSQ ATLTFEPKRG LGVDNTTPVA
     MLEWEDSAGD HRSDDLIANP PVVA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024